Originated by VidaPeps LLC, which attests it authorized this test as the brand of record.
Axiom confirmed this brand is a registered Axiom account. This does not confirm the product's origin, chain of custody, or that the brand authorized this specific test.
Molecular Mass Fingerprinting
Cerebrolysin is a standardized porcine brain-derived peptide preparation of low-molecular-weight neuropeptides (<10 kDa) and free amino acids. Molecular mass fingerprinting by LC-MS/MS (ESI+) confirms the characteristic active-fraction marker neuropeptide MIF-1 (prolyl-leucyl-glycinamide, C13H24N4O3), observed [M+H]+ consistent with the neutral average monomer mass of 284.36 Da. Observed 283.96 Da is within 0.40 Da of theoretical, confirming identity. The characteristic low-MW neuropeptide profile is consistent with authentic Cerebrolysin.
All analytical testing, validation reports, and interactive Certificates of Analysis (COAs) provided by Axiom Analytics are intended strictly for Research Use Only (RUO) in in-vitro or laboratory animal model environments. Axiom Analytics does not analyze, validate, evaluate, or make any representations regarding the safety, efficacy, toxicity, or legality of any tested substance for human or animal consumption, veterinary use, clinical diagnostics, food additives, cosmetics, or household applications.
To the maximum extent permitted by applicable law, the cumulative liability of Axiom Analytics, its officers, employees, and third-party laboratory partners to the client or any third party for any claims, losses, damages, or liabilities of any kind (including but not limited to direct, indirect, special, incidental, punitive, or consequential damages) shall be strictly limited to, and shall not exceed, the exact dollar amount paid by the client to Axiom Analytics for the specific individual analytical test run from which the liability arose.